Document is current
Any future updates will be listed below
-
Authors
Vandewalle, Björn
Castaman, Giancarlo
Álvarez-Román, Maria Teresa
Ettingshausen, Carmen Escuriola
Nemes, László
Tomic, Radovan
Martins, Paulo
Rodrigues, Joana F.
Pinachyan, Karen
- License Information
-
More Information
Article History
Received: 19 January 2024
Accepted: 21 August 2024
First Online: 4 September 2024
Competing interests
: BV and PM are employed by Exigo Consultores, contracted by CSL Behring for the development of the research project. GC has served on advisory committees/speaker for Baxalta, Bayer, CSL Behring, Kedrion, Novo Nordisk, Pfizer, Roche, SOBI and UniQure and received research support from Pfizer, SOBI and CSL Behring. MTAR has participated as speakers in advisory boards and sponsored symposia with Amgen, CSL Behring, Grifols, Novartis, Novo Nordisk, Octapharma, Pfizer, Roche, SOBI and Takeda. CEE has acted as a consultant, and received speaker’s fees and/or research funding from Alnylam, Bayer, Biotest, CSL Behring, Grifols, Kedrion, Octapharma, Novo Nordisk, Roche, SOBI, Takeda, LN has received speaker or consultancy fees from Bayer, CSL Behring, Novo Nordisk, Octapharma, Pfizer, Roche, SOBI and Takeda. RT, JR and KP are employees of CSL Behring.
